Start using the enhanced Field Underwriting Guide today!
November 18, 2026
The new version is designed to help you better assess a Client’s potential life or critical illness underwriting risk before submitting an application.
What’s new?
- Expanded content: Additional examples and expanded medical and lifestyle listings, with enhanced guidance on underwriting risk factors, unique requirements, and preliminary potential life and CI outcomes.
- Digital underwriting guidance: Sun eApp is highlighted as the primary application route, with enhanced explanations of Point of Sale/Instant Approval, Straight Through Underwriting (STU), and how automated and manual underwriting work in synergy.
Major changes
- A new section on ovarian cancer has been added.
- Type 1 and Type 2 diabetes: Expanded with enhanced age-based assessment ranges and greater emphasis on diabetes control, duration, complications and other risk factors.
- Breast cancer – Critical Illness: A history of breast cancer is no longer automatically a decline in all cases. Depending on cancer type and stage, time since last treatment and follow-up compliance, some Clients may now be eligible for meaningful CI coverage for all other conditions, such as heart attack, stroke and other cancers.
- Thyroid cyst/nodule – Life: Assessment is now more granular based on TI-RADS category, nodule size, time since initial finding, follow-up compliance and improving stability.
- Sleep apnea – Life: Suspected obstructive sleep apnea with a sleep study not yet completed may now be considered at 150% in favourable circumstances, including BMI under 30, no traffic accidents and no ratable comorbidities or complications. The guidance also distinguishes outcomes for untreated or non-compliant mild, moderate and severe OSA, taking Sunlife from a conservative approach to one of the leaders in these types of conditions.
- ADHD – Life and CI: The updated framework places greater emphasis on age, severity, functioning, treatment and comorbidities, improving the chance of insurability of those affected.
- Autism Spectrum Disorder – Life and CI: Guidance now follows a severity-based approach rather than relying primarily on age, improving the possibility of coverage before age 9, which had traditionally been a decline.
- Foreign travel: The guide retains the Government of Canada travel-advisory framework but adds an important risk-management measure for specified destinations. The guide also identifies exceptions for disclosed future travel to Turkey, Egypt and Pakistan, where full travel details, including duration and frequency, should be obtained and the Underwriting Department or Sunlife Select consulted. Destination, reason for travel, length of stay and frequency remain key assessment considerations.
Other guide-level updates include refreshed smoking definitions and expanded MIB guidance.
Minor changes
- Breast cyst/nodule – CI: BI-RADS 3 guidance now allows a 150% rating or an exclusion for breast and ovarian cancer, rather than an exclusion-only approach.
- Other medical-condition updates: Guidance has also been revised for Addison’s disease, iron deficiency anemia, hydronephrosis and intellectual disability, all designed to improve our assessment on these conditions.
Thank you for your attention and continued commitment to underwriting excellence.
Call-to-action:
- Download the new Field Underwriting Guide for full details.
Contact us
For more information, reach out to your Sunlife representative.